Rheumatology Advisor
LightNews LightNews
banner
rheumatologyadv.bsky.social
Rheumatology Advisor
@rheumatologyadv.bsky.social
37 followers 7 following 140 posts
RheumatologyAdvisor.com offers healthcare professionals a robust knowledge base of practical rheumatology information to assist in clinical decision making.
Posts Replies Media Videos
rheumatologyadv.bsky.social
Adults with #PsoriaticArthritis who engaged with a digital behavior-change platform experienced weight reduction and corresponding improvements in disease activity compared with those receiving standard care.

https://www.rheumatologyadvisor.com/news/digital-weight-management-psoriatic-arthritis/
Digital Weight Management App Improves PsA Outcomes
Patients with psoriatic arthritis who regularly used a digital weight management app achieved greater weight loss and reduced disease activity.
www.rheumatologyadvisor.com
October 6, 2026 at 9:17 PM
rheumatologyadv.bsky.social
Families of children who prefer a language other than English initiate fewer communications with their care providers compared with English speakers, highlighting a disparity in patient outreach.

https://www.rheumatologyadvisor.com/news/language-barriers-family-communication-pediatric-rheumatology/
Language Barriers Reduce Family Outreach in Pediatric Rheumatology
Language barriers in pediatric rheumatology are associated with reduced family-initiated communication despite similar provider outreach.
www.rheumatologyadvisor.com
October 6, 2026 at 3:07 PM
rheumatologyadv.bsky.social
The presence of #osteoarthritis in multiple joints, particularly involving the knee, serves as a strong predictor for accelerated physical decline and worsening frailty in older adults.
https://www.rheumatologyadvisor.com/news/multijoint-osteoarthritis-accelerates-frailty/
Frailty Progresses Faster in Patients With Multijoint Osteoarthritis
Older adults diagnosed with multijoint osteoarthritis face a significantly higher risk for rapid frailty progression than those without the disease.
www.rheumatologyadvisor.com
October 5, 2026 at 7:54 PM
rheumatologyadv.bsky.social
Vitamin D may have a potential role as a biomarker of disease course in #AxialSpondyloarthritis, but additional studies are needed to confirm whether vitamin D levels improve clinical outcomes.

https://www.rheumatologyadvisor.com/news/vitamin-d-disease-activity-axial-spondyloarthritis/
Adequate Vitamin D Supports Better Control of Axial Spondyloarthritis
Higher serum vitamin D levels are associated with reduced disease activity and improved functional outcomes in radiographic axial spondyloarthritis.
www.rheumatologyadvisor.com
October 3, 2026 at 4:30 PM
rheumatologyadv.bsky.social
The prevalence of moderate to severe joint pain in US adults did not significantly change between 2019 and 2023, falling short of the Healthy People 2030 target, researchers concluded in @acr-journals.bsky.social.

https://www.rheumatologyadvisor.com/news/joint-pain-us-adults-arthritis/
Moderate to Severe Joint Pain Remained Common Among US Adults With Arthritis
The number of US adults with moderate to severe joint pain remained unchanged from 2019 to 2023.
www.rheumatologyadvisor.com
October 2, 2026 at 8:15 PM
rheumatologyadv.bsky.social
Initiating biologic therapy within 2 years of diagnosis or at a later stage produces comparable short-term improvements in joint & skin manifestations of #PsoriaticArthritis. (@acr-journals.bsky.social)

https://www.rheumatologyadvisor.com/news/early-vs-late-biologic-therapy-psoriatic-arthritis/
Early vs Late Biologic Initiation Yields Similar Outcomes in PsA
Patients with psoriatic arthritis experience similar short-term joint and skin improvements regardless of when biologic therapy is initiated.
www.rheumatologyadvisor.com
October 2, 2026 at 2:12 PM
rheumatologyadv.bsky.social
In adults with polymyalgia rheumatica, treatment with IL-6Ri facilitates successful tapering and cessation of glucocorticoid therapy more effectively than conventional synthetic immunomodulators.

https://www.rheumatologyadvisor.com/news/il-6-inhibitors-glucocorticoid-use-polymyalgia-rheumatica/
IL-6 Inhibitors Reduce Glucocorticoid Use in Polymyalgia Rheumatica
Interleukin-6 receptor inhibitors are associated with greater reductions in glucocorticoid use among patients with polymyalgia rheumatica.
www.rheumatologyadvisor.com
October 1, 2026 at 2:36 PM
rheumatologyadv.bsky.social
The 6-minute walk test is a reliable clinical screening tool to identify decreased cardiorespiratory fitness and evaluate cardiometabolic risk in patients with #PsoriaticArthritis. @acr-journals.bsky.social

https://www.rheumatologyadvisor.com/news/6-minute-walk-test-psoriatic-arthritis-fitness/
Six-Minute Walk Test May Help Detect Impaired Fitness in Psoriatic Arthritis
The 6-minute walk test is an effective screening tool for identifying impaired cardiorespiratory fitness in patients with psoriatic arthritis.
www.rheumatologyadvisor.com
September 29, 2026 at 9:16 PM
rheumatologyadv.bsky.social
The presence of hand #synovitis, particularly when bilateral or affecting multiple joints, is associated with a significantly higher risk for all-cause mortality among older adults.

cc: @acr-journals.bsky.social

https://www.rheumatologyadvisor.com/news/hand-synovitis-all-cause-mortality-risk/
Hand Synovitis May Signal Elevated All-Cause Mortality Risk
The presence of hand synovitis is associated with a significantly higher risk for all-cause mortality among middle-aged and older adults.
www.rheumatologyadvisor.com
September 29, 2026 at 6:59 PM
rheumatologyadv.bsky.social
The addition of a specialized smartphone application to standard therapy significantly enhances self-reported disease control, physical mobility, and overall well-being in adults with #AxialSpondyloarthritis.

https://www.rheumatologyadvisor.com/news/smartphone-app-axial-spondyloarthritis-outcomes/
September 23, 2026 at 6:18 PM
rheumatologyadv.bsky.social
While #cannabis and #CBD can offer modest symptom relief for chronic pain in rheumatic diseases, health care providers should counsel patients on outcomes and drug interactions before use.

Read more: https://www.rheumatologyadvisor.com/features/cannabis-cbd-for-pain-relief-management/
Navigating Cannabis, CBD Use for Pain Management in Rheumatic Diseases
Cannabis and CBD for pain management is common in rheumatic disease but clinicians must weigh modest benefits vs potential drug interactions.
www.rheumatologyadvisor.com
September 23, 2026 at 5:59 PM
rheumatologyadv.bsky.social
In patients with #PsoriaticArthritis who received a biologic therapy, upadacitinib maintains long-term clinical responses & minimal disease activity while demonstrating a consistent safety profile.

https://www.rheumatologyadvisor.com/news/upadacitinib-sustained-disease-control-psoriatic-arthritis/
Upadacitinib Provides Sustained Disease Control in Psoriatic Arthritis
Upadacitinib provides sustained improvements in joint, skin, and pain outcomes over 152 weeks in patients with psoriatic arthritis.
www.rheumatologyadvisor.com
September 22, 2026 at 9:23 PM
rheumatologyadv.bsky.social
The concurrent initiation of #tirzepatide and biologic therapy in patients with PsA and obesity reduces body weight and C-reactive protein levels while enhancing patient-acceptable symptom states.

https://www.rheumatologyadvisor.com/news/tirzepatide-biologics-psoriatic-arthritis-outcomes/
Tirzepatide Plus Biologics May Improve Outcomes in Psoriatic Arthritis
Concurrent use of tirzepatide and biologic therapy reduces body weight and improves skin disease control in patients with psoriatic arthritis.
www.rheumatologyadvisor.com
September 22, 2026 at 3:30 PM
rheumatologyadv.bsky.social
High gestational weight gain and hypertensive disorders during pregnancy elevate the likelihood of juvenile idiopathic #arthritis development in offspring, with weight gain association being pronounced in girls.

https://www.rheumatologyadvisor.com/news/maternal-hypertension-weight-gain-jia-risk/
Maternal Weight Gain, Hypertension Linked to Juvenile Idiopathic Arthritis Risk
High gestational weight gain and hypertensive disorders during pregnancy elevate the risk for juvenile idiopathic arthritis in female offspring.
www.rheumatologyadvisor.com
September 21, 2026 at 8:00 PM
rheumatologyadv.bsky.social
In a real-world rheumatology cohort, glucagon-like peptide-1 receptor agonist therapy led to sustained reductions in body weight, enhanced glycemic control, and decreased levels of systemic inflammatory markers.

https://www.rheumatologyadvisor.com/news/glp-1ra-metabolic-outcomes-rheumatic-diseases/
GLP-1 Receptor Agonists Improve Metabolic Outcomes in Rheumatic Diseases
Patients with rheumatic diseases experience significant weight reduction and improved metabolic markers with GLP-1RA therapy.
www.rheumatologyadvisor.com
September 21, 2026 at 6:18 PM
rheumatologyadv.bsky.social
The majority of older adults don't receive necessary antifracture therapies after a nontraumatic fracture, with disparities in treatment initiation observed across age, sex, and racial demographics.

https://www.rheumatologyadvisor.com/news/low-antifracture-therapy-initiation-older-adults/
Few Older Adults Receive Antifracture Drugs After Nontraumatic Breaks
Older adults who experience a nontraumatic fracture rarely receive prescriptions for recommended antifracture medications after hospitalization.
www.rheumatologyadvisor.com
September 17, 2026 at 1:09 PM
rheumatologyadv.bsky.social
A broad understanding of #fibromyalgia presentation is needed to ensure timely and equitable diagnosis, especially in overlooked patient populations.

(@acr-journals.bsky.social)

Read more: https://www.rheumatologyadvisor.com/news/fibromyalgia-diagnosis-disparities-men-older-adults/
Fibromyalgia Diagnosis Often Missed in Men, Older Adults Despite Meeting Clinical Criteria
Men and older adults are less likely to be diagnosed with fibromyalgia, even when meeting the diagnostic criteria.
www.rheumatologyadvisor.com
September 14, 2026 at 7:58 PM
rheumatologyadv.bsky.social
Health care providers should educate patients on the safe use of over the counter analgesics to prevent adverse effects stemming from inappropriate dosing and drug interactions.

Read more: https://www.rheumatologyadvisor.com/features/otc-medication-analgesics-joint-pain-relief/
Guiding Patients on Safe OTC Medication Use for Joint Pain
Proper rheumatic pain management with OTC medication, analgesics requires careful evaluation of patient comorbidities and drug interactions.
www.rheumatologyadvisor.com
September 14, 2026 at 6:36 PM
rheumatologyadv.bsky.social
From @acr-journals.bsky.social: Incorporating osteoporotic fracture-risk screening and preventive treatments into routine care can close a significant risk-care gap in people with #gout.

Read more: https://www.rheumatologyadvisor.com/news/gout-fracture-risk-osteoporosis-diagnosis-treatment/
Bone Density Screening Lags in Gout Despite Elevated Fracture Risk
Gout is associated with a higher incidence of nonvertebral fractures even though these patients receive less osteoporosis screening and treatment.
www.rheumatologyadvisor.com
September 10, 2026 at 1:38 PM
rheumatologyadv.bsky.social
Racial & ethnic disparities in pain management are driven by social and structural factors that require standardized clinical assessments and equitable care strategies to resolve.

https://www.rheumatologyadvisor.com/features/racial-ethnic-disparities-in-pain-management-for-rheumatic-disease/
Addressing Racial and Ethnic Disparities in Pain Management for Rheumatic Disease
Racial and ethnic disparities in pain management have been reported, from pediatric patients in the ED to older adults with cancer.
www.rheumatologyadvisor.com
September 9, 2026 at 7:55 PM
rheumatologyadv.bsky.social
Targeted interventions are needed to address long-term #hydroxychloroquine adherence and achieve optimal medication blood levels to improve clinical outcomes, researchers concluded in @acr-journals.bsky.social.

https://www.rheumatologyadvisor.com/news/hydroxychloroquine-adherence-ascvd-risk-sle/
Poor Hydroxychloroquine Adherence Tied to Higher ASCVD Risk in SLE
Systemic lupus erythematosus patients with low hydroxychloroquine blood levels and poor adherence face an increased cardiovascular disease risk.
www.rheumatologyadvisor.com
September 9, 2026 at 7:52 PM
rheumatologyadv.bsky.social
From @jrheumatol.bsky.social: Younger patients with systemic #lupus erythematosus face significantly greater capability and opportunity barriers to treatment adherence compared with older populations.

https://www.rheumatologyadvisor.com/news/logistical-barriers-sle-treatment-nonadherence/
Adults Younger Than 30 Years With SLE Face More Barriers to Medication Adherence
Medication nonadherence in systemic lupus erythematosus is highest among younger adults facing access and scheduling barriers.
www.rheumatologyadvisor.com
September 4, 2026 at 9:35 PM
rheumatologyadv.bsky.social
In patients with #AxialSpondyloarthritis, elevated baseline disability index scores are strong independent predictors of difficult to manage disease at 24 weeks.

Read more: https://www.rheumatologyadvisor.com/news/baseline-disability-scores-difficult-to-manage-axial-spondyloarthritis/
Functional Impairment Predicts Difficult-to-Manage Axial Spondyloarthritis
Baseline functional impairment scores can independently predict difficult-to-manage axial spondyloarthritis at early follow-up.
www.rheumatologyadvisor.com
September 4, 2026 at 4:40 PM
rheumatologyadv.bsky.social
Patients with rheumatic disease who are prescribed #opioids frequently experience fragmented pain management & treatment interruptions during transitions between prescribers and care settings.

https://www.rheumatologyadvisor.com/news/opioid-transitions-disrupt-pain-care-rheumatic-disease/
Care Transitions Disrupt Opioid-Related Pain Management in Rheumatic Disease
Patients with rheumatic disease who use prescription opioids often experience disruptions in pain management during care transitions.
www.rheumatologyadvisor.com
September 3, 2026 at 1:19 PM
rheumatologyadv.bsky.social
From @annalsofim.bsky.social: Adding cognitive behavioral therapy or a chronic pain self-management program to a patient-centered prescription #opioid taper does not improve taper success at 12 months.

https://www.rheumatologyadvisor.com/news/patient-centered-opioid-tapering-behavioral-therapy/
Patient-Centered Tapering May Reduce Opioid Use Without Worsening Pain
Adding cognitive behavioral therapy to a patient-centered opioid taper does not improve taper success but may reduce withdrawal symptoms.
www.rheumatologyadvisor.com
September 2, 2026 at 9:31 PM